293 related articles for article (PubMed ID: 33819300)
1. A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors.
Listik E; Horst B; Choi AS; Lee NY; Győrffy B; Mythreye K
PLoS One; 2021; 16(4):e0249558. PubMed ID: 33819300
[TBL] [Abstract][Full Text] [Related]
2. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan.
Looyenga BD; Wiater E; Vale W; Hammer GD
Mol Endocrinol; 2010 Mar; 24(3):608-20. PubMed ID: 20160125
[TBL] [Abstract][Full Text] [Related]
3. Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice.
Li Y; Fortin J; Ongaro L; Zhou X; Boehm U; Schneyer A; Bernard DJ; Lin HY
Endocrinology; 2018 Dec; 159(12):4077-4091. PubMed ID: 30364975
[TBL] [Abstract][Full Text] [Related]
4. Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells.
Liu J; Kuulasmaa T; Kosma VM; Bützow R; Vänttinen T; Hydén-Granskog C; Voutilainen R
J Clin Endocrinol Metab; 2003 Oct; 88(10):5002-8. PubMed ID: 14557487
[TBL] [Abstract][Full Text] [Related]
5. Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells.
Bilandzic M; Chu S; Farnworth PG; Harrison C; Nicholls P; Wang Y; Escalona RM; Fuller PJ; Findlay JK; Stenvers KL
Mol Endocrinol; 2009 Apr; 23(4):539-48. PubMed ID: 19164448
[TBL] [Abstract][Full Text] [Related]
6. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
Chapman SC; Bernard DJ; Jelen J; Woodruff TK
Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
[TBL] [Abstract][Full Text] [Related]
7. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
9. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of inhibin action.
Cook RW; Thompson TB; Jardetzky TS; Woodruff TK
Semin Reprod Med; 2004 Aug; 22(3):269-76. PubMed ID: 15319829
[TBL] [Abstract][Full Text] [Related]
11. Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma.
Florio P; Ciarmela P; Reis FM; Toti P; Galleri L; Santopietro R; Tiso E; Tosi P; Petraglia F
Eur J Endocrinol; 2005 Feb; 152(2):277-84. PubMed ID: 15745937
[TBL] [Abstract][Full Text] [Related]
12. Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes.
Wiater E; Lewis KA; Donaldson C; Vaughan J; Bilezikjian L; Vale W
Mol Endocrinol; 2009 Jul; 23(7):1033-42. PubMed ID: 19372236
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of inhibin signal transduction.
Bernard DJ; Chapman SC; Woodruff TK
Recent Prog Horm Res; 2001; 56():417-50. PubMed ID: 11237224
[TBL] [Abstract][Full Text] [Related]
14. Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin.
Chapman SC; Woodruff TK
Endocrinology; 2003 Dec; 144(12):5640-9. PubMed ID: 14500575
[TBL] [Abstract][Full Text] [Related]
15. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome.
Zhu R; Zhou X; Chen Y; Qiu C; Xu W; Shen Z
J Obstet Gynaecol Res; 2010 Feb; 36(1):138-46. PubMed ID: 20178540
[TBL] [Abstract][Full Text] [Related]
18. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.
Esparza-Lopez J; Montiel JL; Vilchis-Landeros MM; Okadome T; Miyazono K; López-Casillas F
J Biol Chem; 2001 May; 276(18):14588-96. PubMed ID: 11278442
[TBL] [Abstract][Full Text] [Related]
20. A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor.
Bernard DJ; Smith CL; Brûlé E
Trends Endocrinol Metab; 2020 Jan; 31(1):37-45. PubMed ID: 31648935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
